Prevention of rat liver fibrosis and carcinogenesis by coffee and caffeine

Food and Chemical Toxicology

Volumn 64, Issue , 2014, Pages 20-26

  Furtado, Kelly S ^a   Polletini, Jossimara ^a   Dias, Marcos C ^a   Rodrigues, Maria A M ^a   Barbisan, Luis F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Caffeine; Coffee beverages; Liver fibrosis and carcinogenesis; Prevention

Indexed keywords

CAFFEINE; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; DIETHYLNITROSAMINE; MESSENGER RNA; PROTEIN BAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CANCER SIZE; COFFEE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; GENE EXPRESSION; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER FIBROSIS; LIVER LEVEL; LIVER PROTECTION; MALE; NONHUMAN; PRECANCER; RAT; TREATMENT DURATION;

RATTUS;

CAFFEINE; COFFEE BEVERAGES; LIVER FIBROSIS AND CARCINOGENESIS; PREVENTION;

ANIMALS; BLOTTING, WESTERN; CAFFEINE; CARCINOGENESIS; COFFEE; COLLAGEN; GLUTATHIONE TRANSFERASE; LIVER CIRRHOSIS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84890102495     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.11.011     Document Type: Article

References (47)

1. Bissell D.M. Chronic liver injury, TGF-beta, and cancer. Exp. Mol. Med. 2001, 33:179-190.
2. Boettler U., Volz N., Pahlke G., Teller N., Kotyczka C., Somoza V., Stiebitz H., Bytof G., Lantz I., Lang R., Hofmann T., Marko D. Coffees rich in chlorogenic acid or N-methylpyridium induces chemopreventive phase II-enzymes via the Nrf2/ARE pathway in vitro and in vivo. Mol. Nutr. Food Res. 2011, 55:798-2011.
3. Bravi F., Bosetti C., Tavani A., Bagnardi V., Gallus S., Negri E., Franceschi S., La Vecchia C. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007, 46:430-435.
4. Brunelle J.K., Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell Sci. 2009, 122:437-441.
5. Bustin S.A., Benes V., Garson J.A., Hellemans J. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
6. Butt M.S., Sultan M.T. Coffee and its consumption: benefits and risks. Crit. Rev. Food Sci. Nutr. 2011, 51:363-373.
7. Cadden I.S., Partovi N., Yoshida E.M. Review article: possible beneficial effects of coffee on liver disease and function. Aliment. Pharmacol. Ther. 2007, 26:1-8.
8. Catalano D., Martines G.F., Tonzuso A., Pirri C., Trovato G.M. Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig. Dis. Sci. 2010, 55:3200-3206.
9. Cavin C., Marin-Kuan M., Langouet S., Bezencon C., Guignard G., Verguet C., Piguet D., Holzhäuser D., Cornaz R., Schilter B. Induction of Nrf2-mediated cellular defences and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem. Toxicol. 2008, 46:1239-1248.
10. Corrao G., Zambon A., Bagnardi V., D'Amicis A., Klatsky A. Collaborative SIDECIRGroup: Coffee, caffeine, and the risk of liver cirrhosis. Annu. Epidemiol. 2001, 11:458-465.
11. Costentin C.E., Roudot-Thoraval F., Zafrani E.S., Medkour F., Pawlotsky J.M., Mallat A., Hézode C. Association of caffeine intake and histological features of chronic hepatitis C. J. Hepatol. 2011, 54:1123-1129.
12. Duarte G., Farah A. Effect of simultaneous consumption of milk and coffee on chlorogenic acids' bioavailability in humans. J. Agric. Food Chem. 2011, 59:7925-7931.
13. Dupas C., Baglieri A.M., Ordonaud C., Tomé D., Maillard M. Chlorogenic acid is poorly absorbed, independently of the food matrix: A Caco-2 cells and rat chronic absorption study. Mol. Nutr. Food Res. 2006, 50:1053-1060.
14. Fallowfield J.A., Kendall T.J., Iredale J.P. Reversal of fibrosis: No longer a pipe dream?. Clin. Liver Dis. 2006, 10:481-497.
15. Fujise Y., Okano J.-I., Nagahara T., Abe R., Imamoto R., Murawaki Y. Preventive effect of caffeine and curcumin on hepatocarcinogenesis in diethylnitrosamine-induced rats. Int. J. Oncol. 2012, 40:1779-1788.
16. Furtado K.S., Prado M.G., Aguiar e Silva M.A., Dias M.C., Rivelli D.P., Rodrigues M.A., Barbisan L.F. Coffee and caffeine protect against liver injury induced by thioacetamide in male Wistar rats. Basic Clin. Pharmacol. Toxicol. 2012, 111:339-347.
17. Goodman, D.G., Maronpot, R.R., Newberne, P.M., Popp, J.A., Squire, R.A. 1994. Proliferative and selected other lesions in the liver of rats. In: Guides for Toxicologic Pathology. STP/ARP/AFIP, 1994. Washington, DC.
18. Gressner O.A. In the search of the magic bullet. Gastroenterology 2010, 139:1453-1457.
19. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
20. Hasegawa R., Ogiso T., Imaida K., Shirai T., Ito N. Analysis of the potential carcinogenicity of coffee and its related compounds in a medium-term liver bioassay of rats. Food Chem. Toxicol. 1995, 33:15-20.
21. Heckman M.A., Weil J., Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J. Food Sci. 2010, 75:R77-87.
22. Hernandez-Gea V., Friedman S.L. Pathogenesis of liver fibrosis. Ann. Rev. Pathol. 2011, 6:425-456.
23. Hosaka S., Kawa S., Aoki Y., Tanaka E., Yoshizawa K., Karasawa Y., Hosaka N., Kiyosawa K. Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene. Food Chem. Toxicol. 2001, 39:557-561.
24. Hoshida Y., Fuchs B.C., Tanabe K.K. Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr. Cancer Drug Targets 2012, 12:1129-1159.
25. Huber W.W., Rossmanith W., Grusch M., Haslinger E., Prustomersky S., Peter-Vörösmarty B., Parzefall W., Scharf G., Schulte-Hermann R. Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem. Toxicol. 2008, 46:1230-1238.
26. Katayama M., Donai K., Sakakibara H., Ohtomo Y., Miyagawa M., Kuroda K., Kodama H., Suzuki K., Kasai N., Nishimori K., Uchida T., Watanabe K., Aso H., Isogai E., Sone H., Fukuda T. Coffee consumption delays the hepatitis and suppresses the inflammation related gene expression in the Long-Evans Cinnamon rat. Clin Nutr 2013, pii: S0261-5614(13)00145-3. 10.1016/j.clnu.2013.05.006.
27. Kisseleva T., Brenner D.A. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J. Gastroenterol. Hepatol. 2007, 22:S73-78.
28. Klatsky A.L., Morton C., Udaltsova N., Friedman G.D. Coffee, cirrhosis, and transaminase enzymes. Arch. Intern. Med. 2006, 166:1190-1195.
29. Kuwana T., Newmeyer D.D. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr. Opin. Cell Biol. 2003, 15:691-699.
30. Lee K.J., Choi J.H., Jeong H.G. Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem. Toxicol. 2007, 45:2118-2125.
31. Lefever S., Hellemans J., Pattyn F., Przybylski D.R., Taylor C., Geurts R., Untergasser A., Vandesompele J. RDML consortium. RDML structured language and reporting guidelines for real-time quantitative PCR data. Nucl. Acids Res. 2009, 37:2065-2069.
32. Leung W.W., Ho S.C., Chan H.L., Wong V., Yeo W., Mok T.S. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case control-study. J. Epidemiol. Commun. Health 2011, 65:556-558.
33. Lim Y.S., Kim W.R. The global impact of hepatic fibrosis and end-stage liver disease. Clin. Liver Dis. 2008, 12:733-746.
34. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method 2001, 25:402-408.
35. Modi A.A., Feld J.J., Park Y., Kleiner D.E., Everhart J.E., Liang T.J., Hoofnagle J.H. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010, 51:201-209.
36. Moreno M.G., Chávez E., Aldaba-Muruato L.R., Segovia J., Vergara P., Tsutsumi V., Shibayama M., Rivera-Espinoza Y., Muriel P. Coffee prevents CCl(4)-induced liver cirrhosis in the rat. Hep. Intl. 2011, 5:857-863.
37. Morii H., Kuboyama A., Nakashima T., Kawai K., Kasai H., Tamae K., Hirano T. Effects of instant coffee consumption on oxidative DNA damage, DNA repair, and redox system in mouse liver. J. Food Sci. 2009, 74:H155-61.
38. Ozercan I.H., Dagli A.F., Ustundag B., Ozercan M.R., Bahcecioglu I.H., Celik H., Yalniz M., Poyrazoglu O.K., Ataseven H. Does instant coffee prevent acute liver injury induced by carbon tetrachoride (CCl4)?. Hepatol. Res. 2006, 35:163-168.
39. Pinheiro F., Faria R.R., de Camargo J.L., Spinardi-Barbisan A.L., da Eira A.F., Barbisan L.F. Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murrill in the rat. Food Chem. Toxicol. 2003, 41:1543-1550.
40. Shi H., Dong L., Zhang Y., Bai Y., Zhao J., Zhang L. Protective effect of a coffee preparation (Nescafe pure) against carbon tetrachloride-induced liver fibrosis in rats. Clin. Nutr. 2010, 29:399-405.
41. Shin J.W., Wang J.H., Kangb J.K., Sona C.G. Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats. J. Sci. Food Agric. 2010, 90:450-455.
42. Aguiar e Silva M.A., Vechetti-Junior I.J., Nascimento A.F., Furtado K.S., Azevedo L., Ribeiro D.A., Barbisan L.F. Effects of swim training on liver carcinogenesis in male Wistar rats fed a low-fat or high-fat diet. Appl. Physiol. Nutr. Metab. 2012, 37:1101-1109.
43. Silva, J.P., Ferreira, E.B., Barbisan, L.F., Brigagao, M.R., Paula, F.B., Moraes, G.O., Magalhães, C.S., Azevedo, L. 2013. Organically produced coffee exerts protective effects against the micronuclei induction by mutagens in mouse gut and bone marrow. Food Research International. http://dx.doi.org/10.1016/j.foodres.2013.07.006.
44. Silva-Oliveira E.M., Fernandes P.A., Moraes-Santos T. Effect of coffee on chemical hepatocarcinogenesis in rats. Nutr. Cancer 2010, 62:336-342.
45. Tao K.S., Wang W., Wang L., Cao D.Y., Li Y.Q., Wu S.X., Dou K.F. The multifaceted mechanisms for coffee's anti-tumorigenic effect on liver. Med. Hypotheses 2008, 71:730-736.
46. Tverdal A., Skurtveit S. Coffee intake and mortality from liver cirrhosis. Annu. Epidemiol. 2003, 13:419-423.
47. Wanless I.R. Pathogenesis of cirrhosis. J. Gastroenterol. Hepatol. 2004, 19:S369-371.